| VEGF inhibitors in metastatic renal cell carcinoma: Current therapies and ... - UroToday |
|
|
UroToday Metastatic renal cell carcinoma (RCC) is predominantly refractory to treatment with traditional cytotoxic chemotherapies, and until recently management options were limited to immunotherapy, palliative care, or phase I trials. |